CClinicalTrials.gg
Status unknownNCT04881422Updated May 11, 2021

Sport, Rehabilitation and Nutrition in Multiple Sclerosis: The LINUS Project

An interventional study of B-HIPE (Brief High Impact Preparatory Experience) in Multiple Sclerosis, sponsored by Fondazione Don Carlo Gnocchi Onlus. Status unknown at 1 site in Italy. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2021-05-11.

Sponsored by Fondazione Don Carlo Gnocchi Onlus · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Apr 2021), so the status shown — last known as Recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years 9 months after the study started (first participant enrolled Jul 2018, registered Apr 2021).
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Only a limited percentage of persons with MS (pwMS) participate to multidisciplinary rehabilitation because of poor support, knowledge and motivation. The investigators reasoned that pwMS should be more effectively prepared to increase their adherence. This study propose the implementation of an innovative collaborative approach, called "brief high-impact preparatory experience" (b-HIPE), inspired by an overarching model based on the interplay between competence, motivation and opportunity to increase in a short time awareness and motivation of pwMS.

The aim of the study is the evaluation of its feasibility. For this pilot study the investigator chose a single-group design with repeated measurements at baseline and post intervention.

02

Conditions studied

  • Multiple Sclerosis

Keywords

  • lifestyle
  • multiple sclerosis
  • nutrition
  • rehabilitation
  • motivation
  • adherence
03

In context

Multiple Sclerosis

3,460 studies on the registry are indexed under Multiple Sclerosis; 661 are open to participants now.

This study's planned enrollment of 30 is below the median of 50 across 2,342 interventional studies indexed under Multiple Sclerosis.

Browse Multiple Sclerosis studies →

Lead sponsor

Fondazione Don Carlo Gnocchi Onlus is the lead sponsor of 146 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • aged 18 to 70 years
  • EDSS ranging from 1 to 7.5.
  • pwMS with who are on a western diet
  • stabilized medical therapy and clinical conditions
  • pwMS with a motor control of upper limbs sufficient to maneuver a tiller

Exclusion criteria

Exclusion Criteria:

  • Heavy smoking, alcohol and drugs abuse
  • severe cognitive impairment
  • dysphagia and/or comorbidities requiring protected environments and specific medical assistance
  • blindness and severe visual disturbances (included severe nystagmus)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Experimental group

    A group of pwMS participate in a multidimensional integrate high-motivating rehabilitation program for the change of lifestyle and bad habits.

    Behavioral: B-HIPE (Brief High Impact Preparatory Experience)

Interventions

  • BehavioralB-HIPE (Brief High Impact Preparatory Experience)

    The intervention consists in a one-week intensive rehabilitation in which participants underwent to a multidimensional rehabilitation composed by physical rehabilitation, mental wellbeing, a proper diet and engaging physical activity (a sail course). Digital motivating reinforcements are proposed to the participants with the aim to maintain the correct lifestyle learned in the B-HIPE program.

06

What researchers measure

Primary outcomes

  1. FS-36 Health Related Quality of Life (HRQoL)

    Questionnaire to Measure Health-Related Quality of Life

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  2. The Fatigue Severity Scale (FSS)

    Questionnaire to Measure the fatigue

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  3. Food frequency questionnaire (FFQ)

    Questionnaire to evaluate usual frequency of foods and beverages

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

Secondary outcomes

  1. MSIS29- Multiple Sclerosis Impact Scale

    A scale for the evaluation of the impact of MS on day-to-day life

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  2. MOS Sleep Scale (MOSS)

    A scale for the evaluation of the quality and the quantity of sleep

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  3. Restless Legs Scale (RLS)

    A scale for the evaluation of the restless legs syndrome

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  4. Six minute walking test (6MWT)

    An exercise test used to assess aerobic capacity and endurance

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

  5. Hospital Anxiety and Depression Scale (HADS)

    A self-assessment scale for detecting states of depression and anxiety

    Time frame: Change between the baseline - T0 (before the intervention) and 1 month after the end of the intervention (T1)

07

Study locations

1 of 1 sites recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04881422
Lead sponsor
Fondazione Don Carlo Gnocchi Onlus
Responsible party
Sponsor
First posted
May 11, 2021
Start date
Jul 15, 2018
Primary completion
Dec 31, 2021 (estimated)
Completion
Jun 30, 2022 (estimated)
Last update
May 11, 2021

Study contacts

Laura LM Mendozzi, MD
Contact
lmendozzi@dongnocchi.it
02 40308571 ext. +39

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion